We are delighted to announce that Dr. med. Sophia Stock has received funding from the Else Kröner-Fresenius-Stiftung for her research project entitled “Anti-P329G Adapter CAR T Cells for Modular Therapy of Solid Tumors.”

The project, planned for a duration of 36 months, aims to advance the development of modular CAR T-cell approaches for the treatment of solid tumors.

Congratulations to Sophia on this achievement! We wish her every success with the project and look forward to seeing the results of her research.